EndoScreen, LLC will develop and commercialize a non-invasive blood test for the early detection of endometrial cancer -- cancer of the inner uterine lining in female patients. Our patent-pending technology will be marketed to hospitals and clinics worldwide.

EndoScreen’s technology is being developed by Drs. Kimberly K. Leslie, Charlotte D. Mobarak and Harriet O. Smith from the University of New Mexico.

.:: LATEST NEWS
UNM Scientist Receive Funding